US20230151100A1
University of Texas Southwestern
John D. Minna and Rolf A. Brekken at the University Texas Southwestern Medical Center presented data demonstrating that tumors comprising Kras G12D , p53 −/− STK11 −/− mutant (KPL9-3) mouse lung-cancer derived cells were resistant to anti-PD1 therapy and AXL inhibitors as monotherapies, but were …